CIK 0001384101 · Services-Medical Laboratories (SIC 8071) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 517.1 M | 296.5 M | ||
| Net income (USD) | -34.9 M | -12.6 M | ||
| Diluted EPS (USD/shares) | 0.82 | -0.51 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | 4 | FORM 4 | 2026-10-19 |
| 2026-09-24 | 144 | 144 | |
| 2026-09-22 | 4 | FORM 4 | 2026-09-21 |
| 2026-09-21 | 144 | 144 | |
| 2026-09-16 | 4 | FORM 4 | 2026-09-14 |
| 2026-09-14 | 144 | 144 | |
| 2026-09-14 | 8-K | 8-K items 1.01,2.01,7.01,9.01 | 2026-09-10 |
| 2026-09-04 | 4 | FORM 4 | 2026-09-02 |
| 2026-09-04 | 4 | FORM 4 | 2026-09-02 |
| 2026-09-04 | 4 | FORM 4 | 2026-09-02 |
| 2026-09-04 | 4 | FORM 4 | 2026-09-02 |
| 2026-09-04 | 4 | FORM 4 | 2026-09-02 |
| 2026-09-04 | 4 | FORM 4 | 2026-09-02 |
| 2026-09-04 | 144 | 144 | |
| 2026-09-04 | 144 | 144 | |
| 2026-09-04 | 144 | 144 | |
| 2026-09-03 | 4 | FORM 4 | 2026-09-01 |
| 2026-09-01 | 144 | 144 | |
| 2026-07-31 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-30 | 8-K | 8-K items 2.02,9.01 | 2026-07-30 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-18 |
| 2026-06-18 | 144 | 144 | |
| 2026-06-15 | 4 | FORM 4 | 2026-06-11 |
| 2026-06-15 | 4 | FORM 4 | 2026-06-11 |
| 2026-06-15 | 4 | FORM 4 | 2026-06-11 |
Forms on file (last 1,000): 4 514, 8-K 120, 144 74, SC 13G/A 56, 10-Q 34, 3 21, SCHEDULE 13G/A 19, SC 13G 18. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=VCYT (0.002 USD), /gw/filings/filings?ticker=VCYT&form=8-K, /gw/filings/facts?ticker=VCYT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange